FMD impact on UK supplies "minimal", but exports restricted
This article was originally published in Clinica
Executive Summary
The Medicines and Healthcare products Regulatory Agency (MHRA) has described as "minimal" the impact of restrictions imposed on the UK supply of medical devices containing UK-sourced animal tissue, in light of the current foot and mouth disease (FMD) outbreak. Restrictions do affect, however, the export of UK-sourced component materials. Details of the issues surrounding such devices and reagents were posted on the MHRA website on August 14, following "detailed discussions" with the Department for Environment, Food and Rural Affairs.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.